Newsroom

Original research article published on April 18, 2018 in Circulation.

DOI: https://doi.org/10.1161/CIRCULATIONAHA.117.032184 Circulation. 2018;CIRCULATIONAHA.117.032184

Download PDF from Circulation here

July 10–13, 2017 - BCVS Scientific Sessions 2017
Exemplar Genetics presented an Oral Abstract at the BCVS Scientific Sessions in Portland, Oregon titled "A MiniSwine Genetic Model of Hypertrophic Cardiomyopathy". Review the abstract in its entirety here
Wednesday, March 22, 2017 10:45 AM
John Swart, founder and president of Exemplar Genetics, won this year's Cultivation Corridor Iowa Biotech Leadership Award, which recognizes leadership, innovation, advocacy and commitment in the biotech industry. Swart founded the company in 2008 in Sioux Center to develop specialized miniature swine models that exhibit human disease states to help test whether medications and devices work. Former Monsanto executive Ted Crosbie, who died last year, also was recognized for his contributions to the industry.
Sioux Center, IA - September 13, 2016

Exemplar Genetics, a wholly owned subsidiary of Intrexon Corporation (NYSE: XON) committed to enabling the study of life-threatening human diseases, today announced two publication in the current issue of the Journal of Clinical Investigation (JCI) demonstrating the potential of ExeGen® CFTR MiniSwine research models to help define and develop effective gene therapies for cystic fibrosis.

SIOUX CENTER, Iowa, April 27, 2016
Read the full article here

First Genetically Engineered Miniswine Research Model Cleared by FDA for Commercial Use

By Jenny Rood | August 1, 2016

The state’s industry draws inspiration from medicine as well as agriculture.

November 12 - 16, 2016 | New Orleans, Louisiana

Find Exemplar Genetics at the upcoming American Heart Association's Scientific Sessions 2016 at the New Orleans Ernest N. Morial Convention Center.

This event features five days of the best in science and cardiovascular clinical practice covering all aspects of basic, clinical, population and translational content. The scope and quality of the scientific exchange make Scientific Sessions the premier cardiovascular research and instructional meeting in the world.

Pages